科研之友
微信
新浪微博
Facebook
分享链接
摘要
Our patients with multiple sclerosis (MS) frequently inquire about the safety and efficacy of an annual influenza vaccination. Influenza remains a leading cause of mortality in the United States, with an estimated 20,000 deaths or more annually. Approximately 40% of all adults in the United States are vaccinated annually. The necessity of vaccination is particularly compelling for those with MS, who are twice as likely to be admitted for influenza compared to those without MS.(1) What should we tell our patients regarding vaccinations and their disease-modifying therapy?
- 出版日期2015-3-3
